Elevated risk of type 2 diabetes for development of Alzheimer disease: A key role for oxidative stress in brain

Butterfield, D. Allan, Di Domenico, Fabio, Barone, Eugenio·2014·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
DOI 10.1016/j.bbadis.2014.06.010

Cites (227)

Items 201–227 of 227

  1. Suppression of Glial HO-1 Activitiy as a Potential Neurotherapeutic Intervention in AD
    Hyman M. Schipper, Ajay Gupta, Walter A. Szarek · 2009 · Current Alzheimer Research
  2. Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats
    Myfanwy J. Borel, J. L. Beard, Peter A. Farrell · 1993 · American Journal of Physiology-Endocrinology and Metabolism
  3. Type 2 diabetes and/or its treatment leads to less cognitive impairment in Alzheimer's disease patients
    Raúl Omar Domínguez, Enrique R. Marschoff, Silvia González, Marisa Gabriela Repetto, Jorge A. Serra · 2012 · Diabetes Research and Clinical Practice
  4. Rosiglitazone Improves Spatial Memory and Decreases Insoluble Aβ1–42 in APP/PS1 Mice
    Julie-Ann O’Reilly, Marina A. Lynch · 2011 · Journal of Neuroimmune Pharmacology
  5. Oxidative Stress Affects Synaptosomal γ-Aminobutyric Acid and Glutamate Transport in Diabetic Rats
    Ana Isabel Duarte, Maria S. Santos, Raquel Maria Fino Seiça · 2004 · Diabetes
  6. High-fat diet increases tau expression in the brain of T2DM and AD mice independently of peripheral metabolic status
    Mari Takalo, Annakaisa Haapasalo, Henna Martiskainen, Kaisa M. A. Kurkinen, Henna Koivisto, Pasi Miettinen, Vinoth Kumar Megraj Khandelwal, Susanna Kemppainen, Dorota Kamińska, Petra M. Mäkinen et al. · 2014 · The Journal of Nutritional Biochemistry
  7. Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease
    Rachna Gupta, Lalit Kumar Gupta · 2012 · Pharmacology Biochemistry and Behavior
  8. Redox proteomics: understanding oxidative stress in the progression of age-related neurodegenerative disorders
    D. Butterfield, R. Sultana · 2008 · Espert Review of Proteomics
  9. Blood-brain barrier dysfunction and amyloid precursor protein accumulation in microvascular compartment following ischemia-reperfusion brain injury with 1-year survival
    Ryszard M. Pluta · 2003 · Springer eBooks
  10. Transcortical Direct Current Potential Shift Reflects Immediate Signaling of Systemic Insulin to the Human Brain
    Manfred Hallschmid, Bernd Schultes, Lisa Marshall, Matthias Mölle, Werner Kern, Julia Bredthauer, Horst Lorenz Fehm, Jan Born A · 2004 · Diabetes
  11. Oxidative Damage in Rat Brain During Aging: Interplay Between Energy and Metabolic Key Target Proteins
    Fabio Di Domenico, Marzia Perluigi A, David Allan Butterfield, Carolin Cornelius, Vittorio Calabrese · 2010 · Neurochemical Research
  12. Defective Glucose-Stimulated Insulin Release in the Diabetic Goto-Kakizaki (GK) Rat Coincides with Reduced Activity of the Islet Carbon Monoxide Signaling Pathway
    Henrik Mosén, Albert A. Salehi, Per Alm · 2004 · Endocrinology
  13. Nitric oxide inhibits, and carbon monoxide activates, islet acid α-glucoside hydrolase activities in parallel with glucose-stimulated insulin secretion
    Henrik Mosén, Albert A. Salehi, Ragnar N. Henningsson, Ingmar Lundquist · 2006 · Journal of Endocrinology
  14. Increased Susceptibility to Amyloid-β Toxicity in Rat Brain Microvascular Endothelial Cells under Hyperglycemic Conditions
    Cristina Carvalho, Paige S. Katz, Somhrita Dutta, Prasad V. G. Katakam, Paula Isabel Moreira, David W. Busija · 2013 · Journal of Alzheimer s Disease
  15. Increased Insulin Sensitivity in Iron-Deficient Rats
    Peter A. Farrell, John L. Beard, Marlin Druckenmiller · 1988 · Journal of Nutrition
  16. Study of the effect of inhibiting galanin in Alzheimer's disease induced in rats
    Azza Baraka, Samar ElGhotny · 2010 · European Journal of Pharmacology
  17. Activation of proteasome by insulin-like growth factor-I may enhance clearance of oxidized proteins in the brain
    Elizabeth P. Crowe, Christian Sell, Jeff D. Thomas, Gregg J. Johannes, Claudio A. Torres · 2009 · Mechanisms of Ageing and Development
  18. Amyloidosis, advanced glycation end products and Alzheimer disease
    Mark A. Smith, Vincent M. Monnier, Lawrence M. Sayre, George L. Perry · 1995 · Neuroreport
  19. The antidiabetic gutsy role of metformin uncovered?
    Rémy Burcelin · 2013 · Gut
  20. Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer’s disease and decreases it in wild-type mice
    Elena Galea, Douglas L. Feinstein, Pierre M. Lacombe · 2006 · Diabetologia
  21. Oxidative stress in Alzheimer's and vascular dementias: masking of the antioxidant profiles by a concomitant Type II diabetes mellitus condition
    Jorge A. Serra, Enrique R. Marschoff, Raúl Omar Domínguez, Eduardo M. Guareschi, Arturo L. Famulari, Miguel Angel Pagano, Eugenia Sacerdote de Lustig · 2003 · Journal of the Neurological Sciences
  22. Insulin‐Induced Oxidative Neuronal Injury in Cortical Culture: Mediation by Induced N‐Methyl‐D‐aspartate Receptors
    Kyung‐Min Noh, Jong‐Cheol Lee, Young‐Ho Ahn · 1999 · IUBMB Life
  23. Injection of β-amyloid into the hippocampus induces metabolic disturbances and involuntary weight loss which may be early indicators of Alzheimer’s disease
    Daily James, Suna Kang, Sunmin Park · 2014 · Aging Clinical and Experimental Research
  24. Glial Glutamate Transporters
    A. Nieoullon · 2009 · Elsevier eBooks
  25. Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate
    Ichiro Nakatsuka, Shigeru Maeda, Tsugunobu Andoh · 2009 · Redox Report
  26. Alpha‐lipoic acid does not alter stress protein response to acute exercise in diabetic brain
    Jani Lappalainen, Zekine Lappalainen, Niku Oksala, David Elliot Laaksonen, Savita Khanna, Chandan K. Sen, Mustafa Atalay · 2010 · Cell Biochemistry and Function
  27. Untitled work
    Nilsson · 1999 · 10.1002/(sici)1097-4695(19990615)39:4